case_images: PMC9400745_01
case_images: Axial section image of CT scan showing heterogeneously enhancing mass lesion in the head of pancreas (A) and right lobe of liver (B)
case_images: etat-03-100289-g001.jpg
case_images: PMC9400745_01_etat-03-100289-g001.jpg
case_images: F1
case_images: Triple phase contrast-enhanced computed tomography (CT) of abdomen revealed a well-defined mass lesion of size 40 mm x 47 mm x 48 mm in close relation to the head of pancreas and another well-defined lesion of size 48 mm x 33 mm in segment VII of the right lobe of liver with both lesions showing arterial phase enhancement (Figure 1).
case_images: Axial, coronal, and sagittal section images of 68Ga DOTANOC PET CT scan showing enhancing lesion in the head of pancreas
case_images: etat-03-100289-g002.jpg
case_images: PMC9400745_01_etat-03-100289-g002.jpg
case_images: F2
case_images: The 68Ga DOTA-NOC PET CT scan [somatostatin receptor (SSTR) PET CT] showed active SSTR expressing lobulated, centrally necrotic mass lesion with intense DOTA-NOC avidity [standardized uptake value (SUV) max-38.2] involving the head of pancreas measuring approximately 43 mm x 50 mm x 48 mm, closely abutting the duodenum and inferior vena cava (Figure 2).
case_images: Axial section images of 68Ga DOTA-NOC PET CT scan showing enhancing lesions in the segment VII of liver (SUV max-14.7) and head of pancreas (SUV max-38.2)
case_images: etat-03-100289-g003.jpg
case_images: PMC9400745_01_etat-03-100289-g003.jpg
case_images: F3
case_images: Another active SSTR expressing tracer avid lesion (SUV max-14.7) was noted in segment VII of liver measuring 40 mm x 38 mm, suggestive of metastatic disease (Figure 3).